Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMS 2022 | Current status of induction therapy for multiple myeloma

Mohamad Mohty, MD, PhD, Saint-Antoine Hospital, Paris, France, discusses induction therapy for multiple myeloma, highlighting the remarkable efficacy of daratumumab-based quadruplet therapies. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.